Review on Clinical Perspective of Multiple Substance use Disorder and its Ayurvedic Management
DOI:
https://doi.org/10.48165/IRJAY.2024.70209Keywords:
CBT, Family therapy, Madatyaya, Multiple substance use, Rasayana, Satvavajaya, WithdrawalAbstract
Background: Substance use disorder (SUD) is a condition in which there is uncontrolled use of a substance despite harmful consequences. Multiple Substance Use Disorders (MSU) include two or more substances taken together or within a short time period, either intentionally or unintentionally. This may lead to problems such as health issues, disability, failure to meet work responsibilities, and difficulties at school and home. Studies have concluded that opiates, cannabis, amphetamines, hallucinogens, inhalants, and benzodiazepines are often used in combination as well. This leads to social, academic, and occupational impairment, along with possible negative health effects. Individuals who abuse one substance are more likely to use other substances as well. Among those aged 12 or older, 61.2 million people (i.e., 21.9% of the population) used illicit drugs in the past year. Objective: To highlight the Ayurvedic clinical perspective in the management of multiple SUDs. Method: In Ayurveda, SUD may be approached by adapting the management principles of madatyaya after assessing the dosha combination as per the clinical presentation. Several combinations useful for the management of the condition, including addiction and withdrawal management, are explained. Ashtanga Lavana, Ajmodarka, Sreekandasava, and Drakshadi Kwatha are some of the medicines used internally to reduce withdrawal symptoms. Panchakarma therapies, along with yoga and Satvavajaya Chikitsa, including family therapy, have a very good outcome in managing substance withdrawal, dependence, and even inpreventing relapse. Results: By adopting the Ayurvedic principles, the outcome of MSU management may be enhanced, and the relapse may also be possible to reduced with the biopsychosocial approach. Conclusion: Evidence-based clinical studies are the need of the hour so as to prove the authenticity of such a clinical perspective explained in Ayurvedic parlance.
Downloads
References
Graae C. A short note on substance abuse. J Alcohol Drug Depend 2022;10:362.
Perry CJ, Zbukvic I, Kim JH, Lawrence AJ. Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol 2014;171:4636-72. 3. Sharma D. Understanding Drug Abuse and Addiction. United States:
National Institute on Drug Abuse; 2012. Available from: https://nida. nih.gov/publications/drugfacts/understanding-drug-use-addiction [Last accessed on 2015 Feb 12].
International Classification of Diseases 11th Revision - ICD-11. Disorders Due to Substance use or Addictive Behaviours. Geneva: World Health Organization; 2023. Available from: https://icd.who. int/en. [Last accessed on 2023 Apr 10].
Cicero TJ, Ellis MS, Kasper ZA. Polysubstance use: A broader understanding of substance use during the opioid crisis. Am J Public Health 2020;110:244-50.
McLellan AT. Substance misuse and substance use disorders: Why do they matter in healthcare? Trans Am Clin Climatol Assoc 2017;128:112-30.
John WS, Zhu H, Mannelli P, Schwartz RP, Subramaniam GA, Wu LT. Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients. Drug Alcohol Depend 2018;187:79-87.
McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am 2010;33:511-25. 9. Murthy KR. Sarangdhar, Sarangadhar Samhita of Acharya Sarangdhar, Edited Purvakandha. Shloka No. 21-22. Reprint/edition. Ch. 4. Varanasi: Chaukhamaba Orientalia; 2016.
Tripathi B. Agnivesh, Charaka Samhita of Acharya Charaka, Charaka and Dhridhavala Krit, Chikitsa Sthana. Shloka No. 56-57. Reprint/ edition. Ch. 24. Varanasi: Chaukhamaba Sanskrit Sansthan; 2013.
Tripathi B. Agnivesh, Charaka Samhita of Acharya Charaka, Charaka and dhridhavala krit, Chikitsa Sthana. Shloka No. 30 Reprint/edition. Ch. 24. Varanasi: Chaukhamaba Sanskrit Sansthan; 2013.
Shastri AD. Sushruta, Sushruta Samhita of Acharya Sushruta, edited with Ayurveda Tayva Sandipika Sharir Sthana. Shloka no. 26. Reprint/ edition. Ch. 6. Varaansi: Chaukhamaba Sanskrit Sansthan; 2010.
Murthy KR. Vriddha Vagbhata, Astanga Samgraha of Acharya Vagbhata Nidan Sthana ver 9. Reprint/edition. Ch. 6. Varanasi: Chaukhamba Sanskrit Sansthan; 2005.
Tripathi B. Agnivesh, Charaka Samhita of Acharya Charaka, Charaka and Dhridhavala krit, Chikitsa Sthana. Shloka No. 37 Reprint/edition. Ch. 24. Varanasi: Chaukhamaba Sanskrit Sansthan; 2013.
Douaihy AB, Kelly TM, Sullivan C. Medications for substance use disorders. Soc Work Public Health 2013;28:264-78.
Shastri AD. Sushruta, Sushruta Samhita of Acharya Sushruta, edited with Ayurveda tayva Sandipika by Uttar Tantra. Shloka no. 19-20. Reprint/edition. Ch. 47. Varaansi: Chaukhamaba Sanskrit Sansthan; 2010.
Behere RV, Muralidharan K, Benegal V. Complementary and alternative medicine in the treatment of substance use disorders-a review of the evidence. Drug Alcohol Rev 2009;28:292-300.
Tripathi B. Agnivesh, Charaka Samhita of Acharya Charaka, Charaka and Dhridhavala Krit, Chikitsa Sthana. Shloka No. 101-102 Reprint/ edition. Ch. 24. Varanasi: Chaukhamaba Sanskrit Sansthan; 2013.
Benni JM, Jayanthi MK, Suresha RN. Evaluation of the anti inflammatory activity of Aegle marmelos (Bilwa) root. Indian J Pharmacol 2011;43:393-7.
Sharma PC, Yelne MB, Dennis TJ, Joshi A. Database on Medicinal Plants Used in Ayurveda. Vol. 1. New Delhi: Central Council for Research in Ayurveda and Siddha, Dept of ISM and H, Min. of Health and Family Welfare, Government of India; 2001. p. 79.
Nand O. List of Psychotherapeutic Drugs/Medicines. New Delhi: Ministry of Health and Family Welfare (Govt of India); 2019. 22. Jagadish A, Ali F, Gowda MR. Mental healthcare act 2017 -the way ahead: Opportunities and challenges. Indian J Psychol Med 2019;41:113-8.
Thirthalli J, Zhou L, Kumar K, Gao J, Vaid H, Liu H, et al. Traditional, complementary, and alternative medicine approaches to mental health care and psychological wellbeing in India and China. Lancet Psychiatry 2016;3:660-72.
Shankar MP. Bhavaprakasha Nighantu of Bhavamishra. Haritakyadi Varga. 1st ed., Ch 77. Ver 221. Varanasi: Chaukhambha Bharati Academy; 2009. p. 267.
Srikantha Murthy KR, editor. Susrutasamhita of Susruta, Suthrasthana; Krithyakrithyavidhi. 1st ed., Ch. 23. Verse 6. Varanasi: Chaukhamba Orientalia; 2014. p. 171.
Sushruta S. In: Shastri KA, editor. Sushruta Samhita, Sutra Sthana, Vamana Dravya Vikalpa Vigyaneeya Adhayaya, 43/5. 11th ed., Vol. 1. Varanasi: Chaukhambha Sanskrit Sansthan; 1997. p. 160.
Veerendra K, Gupta YK. Centella asiatica (L.) Urban: From traditional medicine to modern medicine with neuroprotective potential. Evid Based Complement Alternat Med 2012;2012:946259.
Anand M, Alagesan J. Effect of yoga therapy in rehabilitation of drug addicts. Glob Res Anal 2013;2:154.
Bhargav H, Holla B, Ramakrishna KK, Shivakumar V, Gokulakrishnan K, Varambally S, et al. Yoga and integrative healthcare: Lessons from the national institute of mental health and neurosciences (NIMHANS) in India. Int J Yoga 2022;15:150-7.
Avasthi A, Anthony R. Psychotherapy in Indian context. J Clin Psychiatry 1998-99;3:26-8.
Murthy AR, Singh RH. The concept of psychotherapy in ayurveda with special reference to satvavajaya. Anc Sci Life 1987;6:255-61. 32. Murthy Jaikrishnadas AR. Rationale of Ayurvedic Psychiatry. Ayurveda Series, No.157. Varanasi: Chaukhambha Orientalia; 2009.